79938-45-7Relevant articles and documents
Development of a Selective Inhibitor of Protein Arginine Deiminase 2
Muth, Aaron,Subramanian, Venkataraman,Beaumont, Edward,Nagar, Mitesh,Kerry, Philip,McEwan, Paul,Srinath, Hema,Clancy, Kathleen,Parelkar, Sangram,Thompson, Paul R.
, p. 3198 - 3211 (2017)
Protein arginine deiminase 2 (PAD2) plays a key role in the onset and progression of multiple sclerosis, rheumatoid arthritis, and breast cancer. To date, no PAD2-selective inhibitor has been developed. Such a compound will be critical for elucidating the
Bicyclic compounds with potential antiulcer and/or antisecretory activity. I - 4,5,6,7-tetrahydrobenzimidazoles
Scarponi,Cimaschi,Rusconi,Santangelo,Arcari,Castello,Toti,de Castiglione
, p. 818 - 832 (2007/10/02)
-